E. Hill De Loney, MA (Guidance Counseling), MA (Psychology), Hon PhD, a longtime community partner of MICHR, passed away on May 9, 2024, in Flint, MI, at age 85. Dr. De Loney played a critical role in MICHR and was a pillar of community-based participatory research. She was an invaluable guide to MICHR from the beginning of our CTSA journey in 2007 until her passing and was always a strong voice and advisor for including community leadership in our work.
Are you a U-M staff member who works on health-related research studies? Are you interested in professional growth and development?
If so, consider applying to STEP.up, a MICHR-sponsored formal mentorship program for research staff. We are currently accepting mentor and mentee applications for our sixth cohort.
The MICHR Dissemination & Implementation Science Catalyst Implementation Science Network (DISC-ISN) Pilot Grant is accepting new funding proposals from U-M investigators. All submissions must be received by June 7, 2024 at 11:59 PM EST. The direct costs are limited to $25,000 per year. The maximum project period may not exceed 12 months. Funds can be used for a new standalone project or to enhance an existing research project which examines dissemination or implementation of an effective practice.
In Winter/spring 2024, MICHR will offer the popular Responsible Conduct of Research (RCR) for K Awardees, a seminar that is designed to meet the requirements of the NIH K-23, or any federal or non-federal career development grant.
“I would not be able to do this work without the support of common resources accumulated at MICHR. I value the work I am able to do at U-M and so much of it is enabled by the MICHR team. They are fundamental to getting good clinical research done at Michigan.”
The MICHR Expanded Access program is a fantastic resource. The Expanded Acccess process is pretty complicated, requiring communications with the FDA, the University institutional review board, the pharmaceutical company, and lots of documentation. Early in the COVID-19 epidemic, I worked with the TEAMSS staff to obtain remdesivir for some of our first patients at Michigan Medicine. All I had to do was decide on the drug and they pretty much took care of the rest. They were available after hours and on weekends. They ‘made it happen.’
I was finding research funding options to be very complicated and confusing, until I stumbled upon the MICHR webpage… cue ray of light and angels singing. The resources on this page were exactly what I had been searching for.